Connie M Drysdale

Title: The Innovations of Connie M Drysdale

Introduction

Connie M Drysdale is a notable inventor based in Branford, CT (US). She has made significant contributions to the field of pharmacogenetics, particularly in understanding how genetic variations can influence drug responses. Her work has implications for personalized medicine, allowing for more tailored treatment options for patients.

Latest Patents

Connie M Drysdale holds a patent titled "Association of β2-adrenergic receptor haplotypes with drug response." This patent discloses genotypes and haplotypes for thirteen polymorphic sites in the β-adrenergic receptor (β AR) gene. It also includes compositions and methods for predicting genetic predisposition to diseases associated with these polymorphic sites, as well as for predicting responses to β-agonists.

Career Highlights

Throughout her career, Connie has been associated with Genaissance Pharmaceuticals, Inc., where she has contributed to advancing the understanding of genetic factors in drug response. Her work has been pivotal in bridging the gap between genetics and pharmacology.

Collaborations

Connie has collaborated with esteemed colleagues such as Richard S Judson and Stephen Bryant Liggett. These collaborations have further enriched her research and expanded the impact of her findings in the scientific community.

Conclusion

Connie M Drysdale's innovative work in pharmacogenetics exemplifies the importance of understanding genetic variations in drug responses. Her contributions are paving the way for advancements in personalized medicine, ultimately benefiting patient care.